Clinical Trial Update: Pemetrexed/Platinum With or Without Bevacizumab in Brain Metastases From Patients With EGFR/ALK Negative Non-Squamous Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating pemetrexed/platinum with or without bevacizumab in patients with EGFR/ALK-negative non-squamous non-small cell lung cancer and brain …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non Squamous Non-small Cell Lung Cancer, Brain Metastases | Phase 3 | Status: COMPLETED